V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20200963 | 20088372 | 1.77 | 87 | 03 | 2019-04-06 | 2019-04-25 | Bortezomib + Cyclophos + Dex | 02 | N | PANITUMUMAB | 101546896 |
| 20201166 | 20088373 | 1.64 | 56.9 | null | 2017-10-29 | 2017-11-10 | Amsacrine + FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | null | ESPAC TRIAL | 100687744 |
| 20201296 | 20088374 | 1.88 | 95 | 03 | 2019-10-18 | 2019-10-28 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | EVEROLIMUS | 100501915 |
| 20201314 | 20088375 | 1.61 | 56.6 | Adjuvant (A) | 2018-08-31 | 2018-09-12 | Rituximab | 02 | N | CISPLATIN + RT | 101256435 |
| 20201351 | 20088376 | 1.71 | 89.6 | 03 | 2019-05-14 | 2019-05-14 | PLATO Trials | 01 | N | PLATO TRIAL | 100065020 |
| 20201447 | 20088378 | 1.56 | 69.8 | Palliative (P) | null | 2018-07-21 | PACLITAXEL | 01 | N | ACELARATE TRIAL | 101634245 |
| 20201451 | 20088379 | 1.62 | 101 | Palliative (P) | 2020-04-17 | 2020-04-27 | CARBOPLATIN + FLUOROURACIL | 02 | N | DOCETAXEL | 101639167 |
| 20201521 | 20088380 | 0 | 0 | 03 | 2018-09-07 | 2018-09-28 | Chlorambucil + Pred + Rituximab | 02 | N | CAPE + OXALIPLATIN + TRASTUZUMAB | 100554145 |
| 20201545 | 20088381 | null | null | 03 | 2019-09-28 | 2019-10-16 | EVEROLIMUS | 01 | N | NAB-PACLITAXEL | 100831795 |
| 20201779 | 20088383 | 1.63 | 88 | null | null | 2017-02-21 | SCOPE 2 TRIAL | 2 | N | LETROZOLE + PALBOCICLIB | 100372276 |
| 20201824 | 20088385 | 1.77 | 80 | 03 | 2017-10-14 | 2017-10-14 | Carboplatin + Pemetrexed | null | N | ACELARATE TRIAL | 100763172 |
| 20201913 | 20088386 | 1.63 | 61.5 | 03 | null | 2021-01-25 | MIC | 02 | N | PACLITAXEL | 101718790 |
| 20201920 | 20088387 | 1.67 | 56.5 | 03 | null | 2016-07-09 | Docetaxel 75mg/m2 (21 day) | 02 | Y | IRINOTECAN | 101584942 |
| 20201996 | 20088388 | 1.54 | 83.8 | 03 | null | 2016-01-26 | PLATFORM Trial | 02 | N | IRINOTECAN | 100489506 |
| 20202066 | 20088389 | 1.7 | 59 | 03 | 2019-10-21 | 2019-10-29 | Hydroxycarbamide | 01 | N | GEMCARBO | 101393556 |
| 20202169 | 20088390 | 1.67 | null | 03 | 2018-12-03 | 2018-12-06 | CARBOPLATIN + FLUOROURACIL | N | N | ECARBOX | 100402146 |
| 20202174 | 20088391 | 1.71 | 97.35 | Neo-adjuvant (N) | 2018-08-29 | 2018-09-03 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | GEMCARBO | 101352860 |
| 20202199 | 20088393 | null | 71.6 | 03 | null | 2018-02-26 | Docetaxel | Y | Y | PEMBROLIZUMAB | 101291155 |
| 20202245 | 20088394 | null | null | Palliative (P) | 2018-04-16 | 2018-04-16 | MIC | 02 | N | RALTITREXED | 101283030 |
| 20202279 | 20088396 | 1.72 | 59.5 | null | 2019-11-08 | 2019-11-09 | FCarboSt | 02 | N | CARBOPLATIN + RALTITREXED | 100932037 |
| 20202307 | 20088397 | 1.6 | null | Curative (C) | 2017-02-18 | 2017-02-18 | PACLITAXEL | 02 | N | GEMCITABINE + PACLITAXEL | 100270258 |
| 20202345 | 20088398 | 1.8 | null | null | 2017-03-07 | 2017-03-07 | null | 02 | N | ESHAP | 101572689 |
| 20202424 | 20088399 | null | 68 | Adjuvant (A) | 2016-11-09 | 2016-11-17 | Raltitrexed | 02 | N | OXALIPLATIN | 100818627 |
| 20202435 | 20088400 | 1.83 | 41 | Palliative (P) | 2021-03-24 | 2021-03-25 | NEO-AEGIS TRIAL | 02 | N | PACLITAXEL | 101699061 |
| 20202469 | 20088401 | 1.86 | 80.3 | 03 | 2018-02-08 | 2018-03-06 | Paclitaxel 7 day | 01 | N | ACTICCA-1 TRIAL | 100795823 |
| 20202488 | 20088402 | 1.78 | 53 | null | 2019-12-25 | 2019-12-26 | Irinotecan | 02 | N | GEMCITABINE + PACLITAXEL | 101091633 |
| 20202533 | 20088403 | 1.75 | 59 | 03 | null | 2017-04-30 | EEF or EOF | null | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101795762 |
| 20202543 | 20088404 | 1.7 | 49 | null | 2017-11-21 | 2017-12-23 | Temozolomide + RT | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100765754 |
| 20202570 | 20088405 | 1.81 | 70.6 | 03 | null | 2017-04-30 | MPV (cycle 1-4) | N | N | MELPHALAN + THALIDOMIDE | 100585160 |
| 20202652 | 20088406 | 1.84 | 72.6 | Palliative (P) | 2019-12-13 | 2019-12-16 | MCX | 02 | N | CABAZITAXEL | 101281106 |
| 20202666 | 20088407 | 1.8 | 92.1 | Palliative (P) | 2018-11-10 | 2018-11-12 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101544285 |
| 20202701 | 20088408 | null | null | null | 2019-03-10 | 2019-03-10 | CARBOPLATIN + TEYSUNO | N | N | CHLORAMBUCIL + OBINUTUZUMAB | 101494517 |
| 20202716 | 20088409 | 1.77 | 74.6 | Palliative (P) | 2020-01-14 | 2020-02-28 | BALLAD Trial | null | N | BORTEZOMIB + MELPHALAN | 100129577 |
| 20202778 | 20088410 | 1.74 | 72 | Palliative (P) | 2019-01-16 | 2019-01-30 | Bevacizumab + FLUOROURACIL + IRINOTECAN | 02 | null | RALTITREXED | 100487685 |
| 20202847 | 20088411 | 1.83 | 54.4 | 03 | 2016-07-24 | 2016-07-31 | Palbociclib | 02 | N | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 101635771 |
| 20203002 | 20088413 | 1.67 | 55.9 | 03 | 2017-09-28 | 2017-09-28 | Paclitaxel 7 day | N | Y | BENDAMUSTINE + RITUXIMAB | 100327620 |
| 20203028 | 20088414 | 1.68 | 56.6 | 03 | null | 2018-07-24 | BORTEZOMIB + THALIDOMIDE | 02 | N | GO2 TRIAL | 101548102 |
| 20203047 | 20088415 | 1.63 | 67 | Adjuvant (A) | 2018-11-13 | 2018-11-25 | HEP SIOPEL 3, cisplatin | 02 | N | GEMCITABINE + OXALIPLATIN | 101847148 |
| 20203055 | 20088416 | 1.68 | 72.25 | Palliative (P) | 2018-06-06 | 2018-06-16 | FCarboSt | 2 | N | CISPLATIN + FLUOROURACIL + RT | 100679674 |
| 20203060 | 20088417 | null | 89.3 | Palliative (P) | 2019-02-10 | 2019-02-10 | REGORAFENIB | 02 | N | ACTICCA-1 TRIAL | 101318606 |
| 20203072 | 20088418 | 1.61 | 63.7 | 03 | 2019-05-11 | 2019-05-21 | IPILIMUMAB + NIVOLUMAB | N | N | BORTEZOMIB + THALIDOMIDE | 100822352 |
| 20203145 | 20088419 | 1.72 | 86.6 | 03 | 2019-03-17 | 2019-04-07 | NEO-AEGIS TRIAL | 02 | N | ARISTOTLE TRIAL | 100097984 |
| 20203204 | 20088420 | 1.75 | 73.4 | null | 2018-07-30 | 2018-07-30 | Panitumumab | 02 | N | RITUXIMAB | 101602500 |
| 20203224 | 20088421 | 1.66 | 92 | Palliative (P) | 2019-02-03 | 2019-03-02 | Hydroxycarbamide | 02 | N | MITOMYCIN | 101013896 |
| 20203263 | 20088422 | 1.79 | 86.8 | 03 | null | 2017-05-31 | ACTICCA-1 Trial | null | N | ANAGRELIDE | 100367377 |
| 20203294 | 20088423 | 1.75 | 53 | null | 2017-06-15 | 2017-06-15 | FCarboSt | 02 | N | CISPLATIN + RT | 100046781 |
| 20203300 | 20088424 | 1.98 | 94.5 | Palliative (P) | 2018-03-23 | 2018-04-12 | Hydroxycarbamide | 02 | N | ABIRATERONE | 100541899 |
| 20203355 | 20088425 | 1.48 | 68.6 | 03 | 2017-07-20 | 2017-08-19 | PLATO Trials | 02 | N | PLATO TRIAL | 101802754 |
| 20203394 | 20088426 | null | 11.4 | Palliative (P) | 2017-04-22 | 2017-04-22 | TACE-3 TRIAL | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101785749 |
| 20203429 | 20088427 | 1.57 | 73.8 | 03 | 2017-06-20 | 2017-06-30 | null | 02 | null | LENALIDOMIDE | 101816630 |